​

Nyxoah Stock (NASDAQ:NYXH)

ForecastRevenueFinancialsChartTranscripts
Nyxoah by TradingView

Previous Close

$8.00

52W Range

$4.00 - $20.00

50D Avg

$8.85

200D Avg

$9.51

Market Cap

$274.54M

Avg Vol (3M)

$75.11K

Beta

0.55

Div Yield

-

NYXH Company Profile

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

BE

Employees

146

IPO Date

Apr 28, 2021

Website

NYXH Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
AUSTRIA$122.00K--
Switzerland$373.00K$214.00K-
Spain$37.00K$24.00K-
Germany$3.82M$2.80M-
GERMANY--$800.00K
SPAIN--$24.00K
BELGIUM--$20.00K

Fiscal year ends in Dec 23 | Currency in EUR

NYXH Financial Summary

Dec 23Dec 22Dec 21
Revenue$4.30M$3.08M$852.00K
Operating Income$4.30M$-32.50M$-26.24M
Net Income-$-31.23M$-27.62M
EBITDA-$-25.74M$-22.57M
Basic EPS-$-1.21$-1.16
Diluted EPS-$-1.21$-1.16

Fiscal year ends in Dec 23 | Currency in EUR

Latest Earnings Call Transcripts

Q2 24Aug 11, 24 | 1:44 AM
Q4 23Mar 05, 24 | 6:49 PM
Q3 23Nov 11, 23 | 1:28 PM

Peer Comparison

TickerCompany
MMSIMerit Medical Systems, Inc.
ZJYLJin Medical International Ltd.
ATRCAtriCure, Inc.
KRMDKORU Medical Systems, Inc.
LMATLeMaitre Vascular, Inc.
DXRDaxor Corporation
PDEXPro-Dex, Inc.
UTMDUtah Medical Products, Inc.
NXGLNEXGEL, Inc.